Trial Identifier: | D5136C00008 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02482298 |
Start Date: | July 2015 |
Primary Completion Date: | November 2016 |
Study Completion Date: | November 2016 |
Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English translation | |
Arabic translation | |
Dholou translation | |
French translation | |
Italian translation | |
Turkish translation | |
Swahili translation | |
English translation |
Country | Location |
---|---|
Egypt | Alexandria, Egypt, 21131 |
Egypt | Cairo, Egypt, 11562 |
Egypt | Cairo, Egypt, 11566 |
France | Bordeaux Cedex, France, 33076 |
France | Strasbourg, France, 67091 |
Italy | Verona, Italy, 37134 |
Kenya | Kikuyu, Kenya, 00100 |
Kenya | Kisian, Kenya, 40100 |
Kenya | Nairobi, Kenya, 40100 |
Lebanon | Beirut, Lebanon, 113-6044 |
Lebanon | Beirut, Lebanon, 1107 2020 |
Turkey | Adana, Turkey, 01130 |
Turkey | Mersin, Turkey, 33079 |
Turkey | Van, Turkey, 65080 |
United Kingdom | Harrow, United Kingdom, HA1 3UJ |
United Kingdom | London, United Kingdom, E9 6SR |
United Kingdom | LONDON, United Kingdom, E1 1BB |
United States of America, MD | Bethesda, MD, United States of America, 20817 |
United States of America, SC | Charleston, SC, United States of America, 29425 |